It is a startling accusation: Did two major pharmaceutical firms, in an effort to protect their blockbuster drug, mislead editors at one of the world’s most prestigious medical journals? The claim carries echoes, some say, of an earlier era of drug marketing, when crucial clinical data went missing from journal articles, leading to ethics policies to limit the influence of drug companies on medical literature. “It just feels like it’s a real ethical breach,” said Dartmouth's Dr. Lisa Schwartz.
read more